INS and Alzheimer disease: In addition, clinical studies have shown that patients with AD have decreased expression of insulin receptors and impaired insulin signaling in brain areas susceptible to AD pathology, which could account for the early cognitive impairment seen in these patients (Schiöth et al., 2012).